Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-11

Clinical Trial Update: Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using the ALFApump System to treat ascites in cirrhosis and its effects on renal and circulatory function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFApump System

Snippet

Sponsor: Sequana Medical N.V. | Conditions: Cirrhosis, Liver, Refractory Ascites | Phase 2 | Status: UNKNOWN